## Abstract ## Background It is the purpose of this study to determine the incidence of shoulder pain and restricted range of motion of the shoulder after neck dissection, and to identify risk factors for the development of shoulder pain and restricted range of motion. ## Methods Clinical patien
Botulinum toxin type A for the treatment of chronic neck pain after neck dissection
β Scribed by Claus Wittekindt Vasan; Wei-Chi Liu; Jens-Peter Klussmann; Orlando Guntinas-Lichius
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 123 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
Neck dissection surgery is often followed by chronic head and neck pain. To date optimal treatment of this type of pain is lacking. Botulinum toxin type A (BTXβA) has been shown to be effective in the treatment of myofascial pain syndrome and headache. In a pilot study, we wanted to test the effectiveness of BTXβA for the treatment of chronic neck pain after neck dissection.
Methods.
Sixteen patients with chronic neck pain after neck dissection were included in this prospective, open study. Eighty to 320 units of BTXβA (Dysport) were injected into muscular trigger points. Outcome measures included chronic pain and shooting pain on the basis of visual analog scales and quality of life improvement (EORTC QLQβCβ30; EORTC QLQβH&N35) before and 4 weeks after treatment.
Results.
Patients showed a significant reduction in chronic pain (4.5 before to 3.3 after treatment, p = ,005) and in shooting pain (6.1 before to 4.7 after treatment, p = .005). There was a trend toward improvement in global quality of life (QLQβC30, p = .097) and an increase on the functional scale βpainβ (QLQβH&N35, p = .071).
Conclusions.
BTXβA treatment of subjects with chronic neck pain after neck dissection resulted in a fast and significant reduction of pain. A significant improvement in quality of life may be expected in a longer time course after treatment. Β© 2004 Wiley Periodicals, Inc. Head Neck 26: 39β45, 2004
π SIMILAR VOLUMES
## Abstract ## Background. To define the role of planned neck dissection after definitive radiotherapy for patients with nodeβpositive squamous cell carcinoma of the head and neck. ## Methods. Review of the pertinent literature. ## Results. Radiotherapy alone produces a relatively high likelih
## Abstract For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of
## Abstract ## Background. Acute oral mucositis is associated with pain and impaired swallowing. Little information is available on the effects of chronic mucositis on swallowing. ## Methods. Sixty patients treated for cancer of the head and neck were examined during the first year after their c
## Abstract ## Background. Residual structural abnormalities after definitive treatment of head and neck squamous cell carcinoma (HNSCC) are common and pose difficult management problems. The usefulness of fluorineβ18 fluorodeoxyglucose positron emission tomography (FDG PET) to supplement conventi